These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32158269)

  • 1. Assessment in the Survival Outcome After Transarterial Chemoembolization Combined with Cryoablation for Hepatocellular Carcinoma (Diameter > 4cm) Based on the Albumin-Bilirubin Grade and Platelet-Albumin-Bilirubin ‎grade: ‎ A Preliminary Study.
    Huang Z; Zuo M; Ni J; Gu Y; Zhang T; Jiang Y; Zhuo S; An C; Huang J
    Cancer Manag Res; 2020; 12():1373-1385. PubMed ID: 32158269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; An C; Sun HL; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Int J Hyperthermia; 2019; 36(1):841-853. PubMed ID: 31452408
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
    Lee SK; Song MJ; Kim SH; Park M
    PLoS One; 2019; 14(5):e0216173. PubMed ID: 31048923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Hansmann J; Evers MJ; Bui JT; Lokken RP; Lipnik AJ; Gaba RC; Ray CE
    J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.
    Hu K; Yuan J; Tang B; Zhang F; Lu S; Chen R; Zhang L; Ren Z; Yin X
    Ann Transl Med; 2021 Feb; 9(3):237. PubMed ID: 33708864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Chiou YY; Huang YH; Lee FY; Lin HC; Hou MC; Huo TI
    J Gastroenterol Hepatol; 2017 Apr; 32(4):879-886. PubMed ID: 27696519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT).
    Ho CHM; Chiang CL; Lee FAS; Choi HCW; Chan JCH; Yeung CSY; Huang JJ; Chan MKH; Blanck O; Wong FCS
    Oncotarget; 2018 Jun; 9(48):28818-28829. PubMed ID: 29988960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
    Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
    BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child-Pugh A patients treated with radical surgery: A retrospective observational study.
    Wu B; Hu X; Jin H; Zhou L; Zhang D; Man Z; Wang Y; Yang S; Pang Q; Liu H; Cui P
    Medicine (Baltimore); 2019 Oct; 98(43):e17394. PubMed ID: 31651841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC.
    Zhao S; Zhang T; Li H; Wang M; Xu K; Zheng D; Du X; Liu L
    Ann Transl Med; 2020 Apr; 8(8):538. PubMed ID: 32411761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of pretreatment albumin-bilirubin (ALBI) grade and platelet-albumin-bilirubin (PALBI) grade in patients with small cell lung cancer.
    Kut E; Menekse S
    Sci Rep; 2024 Jan; 14(1):1371. PubMed ID: 38228667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To determine the prognostic value of the albumin-bilirubin grade (ALBI) in patients underwent transarterial chemoembolization for unresectable hepatocellular carcinoma.
    Khalid MA; Achakzai IK; Hanif FM; Ahmed S; Majid Z; Luck NH
    Gastroenterol Hepatol Bed Bench; 2019; 12(2):110-115. PubMed ID: 31191834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis.
    Oikonomou T; Goulis L; Doumtsis P; Tzoumari T; Akriviadis E; Cholongitas E
    Ann Hepatol; 2019; 18(1):126-136. PubMed ID: 31113581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma.
    Lu LH; Zhang YF; Mu-Yan C; Kan A; Zhong XP; Mei J; Ling YH; Li SH; Shi M; Wei W; Guo RP
    Dig Liver Dis; 2019 Oct; 51(10):1430-1437. PubMed ID: 31054962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Do Not Predict Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Khabbaz RC; Lokken RP; Chen YF; Lipnik AJ; Bui JT; Ray CE; Gaba RC
    Cardiovasc Intervent Radiol; 2018 Jul; 41(7):1029-1034. PubMed ID: 29516241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Pretreatment Albumin-Bilirubin Grade as a Better Prognostic Factor Compared to Child-Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy.
    Lee JJB; Park JS; Hong HP; Kim MS; Koo DH; Lee H; Nam H
    J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis.
    Mishra G; Majeed A; Dev A; Eslick GD; Pinato DJ; Izumoto H; Hiraoka A; Huo TI; Liu PH; Johnson PJ; Roberts SK
    J Gastrointest Cancer; 2023 Jun; 54(2):420-432. PubMed ID: 35635637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Young LB; Tabrizian P; Sung J; Biederman D; Bishay VL; Ranade M; Patel RS; Nowakowski FS; Fischman AM; Lookstein RA; Kim E
    J Vasc Interv Radiol; 2022 May; 33(5):510-517.e1. PubMed ID: 35150838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Performance of Albumin-Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib.
    Zhong BY; Yan ZP; Sun JH; Zhang L; Hou ZH; Yang MJ; Zhou GH; Wang WS; Li Z; Huang P; Zhang S; Zhu XL; Ni CF
    Front Oncol; 2020; 10():525461. PubMed ID: 33392064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.